Schedule 13G ownership disclosure
Syndax Pharmaceuticals Inc
Security class unavailable · CUSIP: 87164F105
Event date: 2023-10-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,156,982
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-005275
- Form type
- SC 13G
- Filer
- Point72 Asset Management, L.P.
- CIK
- CIK 1603466
- Filed
- Oct 31, 2023
- Reporting period
- Oct 30, 2023
- Description
- Schedule 13G beneficial ownership